Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fitgenes is an Australian personalized health company focused on DNA-based wellness testing and practitioner-supported nutrition and lifestyle programs. The company markets mouth-swab genetic tests and report products that help consumers and accredited practitioners tailor dietary, fitness, fertility, immune, and wellbeing interventions based on genetic variants. Its offerings are positioned around nutrigenetics and preventive health rather than drug development, with products such as CarbChoice, FoodChoice, Health & Wellbeing Report, FertilityHealth, DietaryChoice, ImmuneHealth, and ActiveChoice. Fitgenes operates through a practitioner network and also supports data conversion from third-party consumer genomics services. The business appears to be commercial-stage, private, and active, with operations centered in Australia and a presence in the Americas via Fitgenes USA.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fitgenes.